Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme

• Main Authors: Md. Sakhawat Hossain (Author), Amresh Kumar (Author), A.F.M Akhtar Hossain (Author), Md. Mahshin (Author), Abhijit Sharma (Author), Md. Akter Hossain (Author), Varun Sharma (Author), Rashidul Haque (Author), A.K.M Shamsuzzaman (Author), Shomik Maruf (Author), Prakash Ghosh (Author), Vivek Ahuja (Author), Dinesh Mondal (Author)
• Format: Book
• Published: BMC, 2018-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Adverse effects of antileishmanial drugs can affect patients' quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). In Bangladesh, there are 26 treatment centers that manage leishmaniasis cases coming from 10...